Correlation Between Passage Bio and Ikena Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Ikena Oncology, you can compare the effects of market volatilities on Passage Bio and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Ikena Oncology.

Diversification Opportunities for Passage Bio and Ikena Oncology

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Passage and Ikena is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Passage Bio i.e., Passage Bio and Ikena Oncology go up and down completely randomly.

Pair Corralation between Passage Bio and Ikena Oncology

Given the investment horizon of 90 days Passage Bio is expected to generate 1.16 times more return on investment than Ikena Oncology. However, Passage Bio is 1.16 times more volatile than Ikena Oncology. It trades about 0.04 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.02 per unit of risk. If you would invest  96.00  in Passage Bio on September 1, 2024 and sell it today you would earn a total of  17.00  from holding Passage Bio or generate 17.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Passage Bio  vs.  Ikena Oncology

 Performance 
       Timeline  
Passage Bio 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Passage Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Passage Bio reported solid returns over the last few months and may actually be approaching a breakup point.
Ikena Oncology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ikena Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Passage Bio and Ikena Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Passage Bio and Ikena Oncology

The main advantage of trading using opposite Passage Bio and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.
The idea behind Passage Bio and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets